Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-21 Sale | 2021-06-23 4:09 pm | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 6,200 | $5.1585 | $31,983 | 165,735 (Direct) | View |
| 2021-06-07 Sale | 2021-06-08 5:32 pm | Adamas Pharmaceuticals Inc | ADMS | DEMSKI MARTHA J Director | 2,000 | $5.17 | $10,340 | 21,000 (Indirect Direct) | View |
| 2021-03-22 Sale | 2021-03-23 6:06 pm | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 1,051 | $5.5 | $5,781 | 169,435 (Direct) | View |
| 2021-03-22 Sale | 2021-03-23 6:02 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 2,422 | $5.48 | $13,273 | 145,017 (Direct) | View |
| 2021-03-11 Purchase | 2021-03-15 3:24 pm | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 5,975 | $5.06 | $30,233 | 15,975 (Direct) | View |
| 2021-02-01 Sale | 2021-02-01 9:39 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 3,821 | $6.36 | $24,302 | 72,439 (Direct) | View |
| 2021-02-01 Sale | 2021-02-01 9:37 pm | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 4,514 | $6.39 | $28,844 | 95,486 (Direct) | View |
| 2021-01-20 Sale | 2021-01-22 5:29 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 2,630 | $4.41 | $11,598 | 76,260 (Direct) | View |
| 2020-11-02 Sale | 2020-11-02 4:44 pm | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 2,050 | $3.21 | $6,581 | 78,890 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-24 Disposition | 2021-11-24 4:11 pm | N/A 2029-06-04 | Adamas Pharmaceuticals Inc | ADMS | BIGHAM MICHAEL Director | 30,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:11 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | BIGHAM MICHAEL Director | 10,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:11 pm | N/A 2029-06-04 | Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director | 70,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:11 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director | 117,781 | $0 | 0 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 75,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:10 pm | N/A 2029-09-15 | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 450,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 600,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 18,750 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:10 pm | N/A 2029-04-07 | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 87,500 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 163,767 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:09 pm | N/A 2029-06-04 | Adamas Pharmaceuticals Inc | ADMS | Ericson William W. Director 10% Owner | 30,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Ericson William W. Director 10% Owner | 4,629,796 | $0 | 0 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 18,750 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:09 pm | N/A 2029-06-06 | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 185,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 186,786 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:09 pm | N/A 2030-11-21 | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 30,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 20,975 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:08 pm | N/A 2030-08-28 | Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director | 30,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:08 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director | 25,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:08 pm | N/A 2029-06-04 | Adamas Pharmaceuticals Inc | ADMS | DEMSKI MARTHA J Director | 30,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:08 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | DEMSKI MARTHA J Director | 21,000 | $0 | 0 (Indirect) | View |
| 2021-11-24 Disposition | 2021-11-24 4:07 pm | N/A 2023-12-12 | Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director | 54,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:07 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director | 202,000 | $0 | 0 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:17 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director | 15,000 | $0 | 35,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:16 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 15,000 | $0 | 30,975 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:15 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director | 15,000 | $0 | 127,781 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:15 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director | 15,000 | $0 | 212,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:14 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | Ericson William W. Director 10% Owner | 15,000 | $0 | 4,639,796 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:13 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | Dier Mardi Director | 15,000 | $0 | 20,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:13 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | DEMSKI MARTHA J Director | 15,000 | $0 | 33,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:12 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | BIGHAM MICHAEL Director | 15,000 | $0 | 20,000 (Direct) | View |
| 2021-03-12 Exercise | 2021-03-16 5:23 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director | 48,000 | $0.665 | 112,781 (Direct) | View |
| 2021-03-12 Exercise | 2021-03-16 5:23 pm | N/A 2021-11-15 | Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director | 48,000 | $0 | 112,781 (Direct) | View |
| 2021-03-12 Exercise | 2021-03-16 5:20 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director | 192,000 | $0.665 | 197,000 (Direct) | View |
| 2021-03-12 Exercise | 2021-03-16 5:20 pm | N/A 2021-11-15 | Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director | 192,000 | $0 | 197,000 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-03 5:01 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 300,000 | $0 | 525,000 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-03 4:59 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 75,000 | $0 | 170,486 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-03 4:56 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 75,000 | $0 | 147,439 (Direct) | View |
| 2020-11-22 Option Award | 2020-11-24 5:57 pm | N/A 2030-11-21 | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2020-11-24 5:52 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 0 | $0 | 0 (Direct) | View |
| 2020-08-29 Option Award | 2020-09-01 4:44 pm | N/A 2030-08-28 | Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director | 30,000 | $0 | 40,000 (Direct) | View |
Ownership | 2020-09-01 4:42 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director | 0 | $0 | 10,000 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 7:42 pm | N/A 2030-06-02 | Adamas Pharmaceuticals Inc | ADMS | Ericson William W. Director 10% Owner | 15,000 | $0 | 4,634,796 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:45 pm | N/A 2030-06-02 | Adamas Pharmaceuticals Inc | ADMS | LIEBERBURG IVAN M Director | 15,000 | $0 | 79,000 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:14 pm | N/A 2030-06-02 | Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director | 15,000 | $0 | 74,781 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:12 pm | N/A 2030-06-02 | Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director | 15,000 | $0 | 15,000 (Direct) | View |